아시아태평양의 차세대 진단약 시장 : 전망(2023년)

The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus on breakthrough innovation, diagnostic services must be revamped to meet reduced price points for low-resource settings.

The pandemic led to a greater focus on preventive diagnosis. Innovation in product development, a focus on care delivery and business models, and the need for more convenient sampling are leading to a paradigm shift to minimally invasive tests. Global IVD powerhouses remain at the vanguard of this transformation. Prominent market participants are Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, and Sysmex Corporation, while regional IVD powerhouses are making a strategic shift to leverage the platform-as-a-service business model, implying momentum in secured and connected open development platforms to support rapid and standardized assay development. Trends point toward a focus on infectious diseases outside COVID-19, molecular oncology, cardiovascular disease, and diabetes, with an emerging focus on noninvasive prenatal testing (NIPT).

Table of Contents

Analysis Highlights

• Study Highlights
• Top Next-generation Diagnostics Industry Predictions-2023

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Next-generation Diagnostics Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Environment

• Segmentation
• Growth Environment

Macroeconomic Factors

• Top 5 Global Economic Highlights-2023
• Global GDP Growth Snapshot
• Advanced Economies' Predictions-2023
• Emerging Economies' Predictions-2023
• Regional Risks and Policy Direction-2023
• Supply Chain Disruptions-Impact Analysis
• Innovation-Impact Analysis
• Commercial Success-Impact Analysis

Revenue Trends

• Revenue Forecast by Segment
• Competitive Environment
• Revenue Share
• Revenue Share Analysis
• Revenue Forecast by Country
• Revenue Forecast Analysis by Country

Top Predictions

• Prediction 1-Infectious Disease Testing will Largely Transition to POC Rapid Tests
• Prediction 2-Comprehensive POCT Solutions in Diabetes Care will Proliferate to Empower Fast Clinical Decision Making
• Prediction 3-A Spike in Population-sequencing Efforts will Drive NGS Market Expansion
• Prediction 4-Demand for Cardiac Biomarker Testing in Hospitals will Drive Clinical Chemistry and Immunoassay Market Growth in China

Next-generation Diagnostics Segment Outlook

• Market Snapshot-2023
• Market Snapshot-Clinical Chemistry and Immunoassays
• Market Snapshot-Molecular Diagnostics
• Market Snapshot-POCT

Growth Opportunity Universe

• Growth Opportunity 1: POC Rapid Testing
• Growth Opportunity 2: NIPT
• Growth Opportunity 3: Comprehensive Cancer Genomic Profiling Services

Conclusions

• Conclusion

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer